• Home
• Resource
• Promoter Capture Hi-C for Mapping Promoter-Enhancer Interactions

Genome-wide association studies (GWAS) and regulatory genomics routinely point to variants and peaks in non-coding DNA. The hard part is rarely finding a regulatory region—it's deciding which gene that region actually regulates. Linear distance is an unreliable guide: an enhancer can skip over the nearest gene, act across long genomic spans, and behave differently across cell types.

This is why "variant-to-gene" and "peak-to-gene" mapping often stalls right when a project needs to move from a list of candidate loci to testable hypotheses. Without evidence that a regulatory element and a promoter come into physical proximity in the nucleus, target-gene assignment can devolve into best-guess heuristics.

Promoter Capture Hi-C (PCHi-C) is designed for this specific bottleneck. It enriches a Hi-C-style library for promoter-containing ligation products, so you can detect promoter-centered contacts with distal regulatory elements more efficiently than with genome-wide Hi-C.

Researchers on the CD Genomics Chromatin3D Genomics team often hear a version of the same question during study-design discussions: "Is genome-wide Hi-C enough for promoter-level questions?" The practical answer is that it depends on your objective, locus complexity, and how sensitively you need to detect promoter interactions—especially when your downstream goal is enhancer target gene identification.

Why promoter–enhancer interactions are difficult to identify

1) Linear genome distance does not equal regulatory relationship

Enhancers can regulate genes that are far away in base-pair distance, sometimes bypassing multiple nearby transcription start sites (TSSs). This creates a familiar failure mode: the "nearest gene" assumption is convenient, but it can mis-assign targets—especially in gene-dense regions or loci with complex regulatory landscapes.

In practice, the question you need to answer is not "Which gene is closest?" but "Which promoter physically and plausibly connects to this regulatory element in the relevant cell state?"

2) Non-coding regions dominate regulatory variation

Many functional variants sit in enhancers, promoters, and other cis-regulatory elements rather than protein-coding sequence. That's why GWAS fine-mapping and epigenomic peak calling often yield strong signals with ambiguous gene attribution. The regulatory code is largely non-coding; the "wiring diagram" that links non-coding elements to genes is the missing layer.

3) Chromatin interaction evidence is often required (and must be interpreted carefully)

Chromatin interaction mapping adds physical proximity evidence: which genomic fragments are ligated together after crosslinking, indicating they were near each other in 3D space. This evidence is powerful for prioritization—but it's not the same as functional proof.

A detected contact supports a hypothesis ("this enhancer could regulate that promoter"), but it does not prove causality on its own. Strong target-gene claims generally benefit from integration with orthogonal evidence (e.g., enhancer activity marks, perturbation readouts, expression changes).

What is Promoter Capture Hi-C (PCHi-C)?

Promoter Capture Hi-C is a targeted chromosome conformation capture method that enriches promoter-containing interactions to improve detection of promoter-centered regulatory contacts.

At a high level, it follows the core principles used in chromatin conformation capture experiments, then adds a promoter capture step using hybridization probes ("baits") designed against promoter-containing restriction fragments.

Workflow overview of Promoter Capture Hi-C for detecting promoter-centered chromatin interactions.

If you're deciding among 3D assays for a promoter-focused question, CD Genomics provides a practical overview in the Hi-C vs Micro-C vs Capture Hi-C vs HiChIP decision guide.

How Promoter Capture Hi-C identifies promoter–enhancer interactions

The value of PCHi-C is not simply that it produces "more data." It produces the right kind of data for promoter-centered inference: a map of which distal genomic regions are statistically enriched among contacts with specific promoters.

Promoter bait design: what is captured

PCHi-C starts by defining a promoter set—typically annotated promoters (and sometimes alternative TSSs, depending on bait design). The capture probes enrich ligation products where one end is a baited promoter fragment.

Implications:

• You gain sensitivity for promoter-centered contacts because sequencing effort is concentrated on promoter-associated ligation products.
• You do not get a complete, unbiased genome-wide interaction map; non-promoter–non-promoter contacts are not the focus.

Interaction detection: how reads become promoter contacts

After sequencing, paired-end reads are mapped back to the reference genome and filtered to retain valid ligation products. For capture data, interaction calling typically uses statistical frameworks designed for capture Hi-C to separate signal from distance-dependent background.

The output is often represented as:

• promoter ↔ promoter-interacting region (PIR) pairs
• promoter-centered contact maps around individual baits
• interaction networks across promoters and their distal partners

Interaction interpretation: connecting enhancers to candidate target genes

To move from "contact" to "candidate regulatory relationship," researchers typically:

1. Identify PIRs that overlap enhancer-like annotations (e.g., accessible chromatin or active enhancer marks).
2. Link those PIRs to the promoter bait they contact.
3. Prioritize target genes by combining contact evidence with orthogonal information (cell-type specificity, eQTL colocalization, differential expression, perturbation outcomes).

Two interpretation points matter in real projects:

• Many-to-many wiring is normal. Promoters often contact multiple distal regulatory elements, and a single enhancer can contact multiple promoters. PCHi-C helps enumerate plausible wiring, but it doesn't guarantee a one-enhancer–one-gene mapping.
• Physical proximity is not equivalent to regulatory effect. Some contacts may be structural or permissive rather than transcriptionally instructive at the time point assayed.

For promoter-centered mapping at defined loci, targeted approaches in the same family (e.g., promoter-focused capture strategies) can also be relevant; see the Capture-C service overview for an example of promoter-focused capture configurations.

Promoter Capture Hi-C vs Hi-C: when targeted mapping is more suitable

Genome-wide Hi-C is excellent for global 3D genome features such as compartments and broad domains, but promoter–enhancer questions tend to be limited by resolution and sensitivity at practical sequencing depths.

A simple decision table is often enough to keep projects from choosing a method that can't answer the actual biological question:

When teams need a broader framework for method selection (including how "targeted capture" differs from antibody-anchored assays), CD Genomics' Hi-C vs Micro-C vs Capture Hi-C vs HiChIP decision guide is a useful reference point.

Applications of Promoter Capture Hi-C in regulatory genomics

Promoter Capture Hi-C is commonly used in Research Use Only settings to support questions like:

1. Enhancer target gene identification

Build promoter-centered maps that connect distal candidate enhancers to specific promoters.

2. Functional interpretation of non-coding variants

When a GWAS signal sits in a non-coding block, promoter-centered contacts can prioritize which genes are plausible downstream targets.

3. Disease mechanism studies

Compare promoter interactomes across relevant cell types or perturbations to refine mechanistic hypotheses (without implying diagnostic use).

4. Cell-type-specific regulatory networks

Derive promoter interaction networks that differ across lineages or activation states—useful for separating "shared architecture" from cell-type-restricted wiring.

Two foundational studies helped establish promoter capture strategies for promoter-centered maps at scale: Schoenfelder and colleagues' promoter capture work in mouse cells (Genome Biology, 2015) and Mifsud and colleagues' promoter contact mapping in human cells (Nature Genetics, 2015).

Promoter Capture Hi-C data analysis and deliverables

A well-run PCHi-C project is judged as much by interpretability as by raw yield. For promoter-centered studies, the deliverables that enable downstream hypothesis testing typically include:

• Raw sequencing files (FASTQ)
• QC report summarizing sequencing and library characteristics
• Mapped and filtered interaction pairs (valid ligation products)
• Promoter-centered contact maps suitable for genome browser visualization
• Significant interaction pairs (promoter ↔ PIR lists with coordinates and statistical scores)
• Annotated promoter-associated contacts, such as overlaps with regulatory features provided by the research team (e.g., ATAC-seq peaks, enhancer marks)

QC should be reported in a way that helps reviewers of the dataset understand what is reliable to interpret. Common QC dimensions include:

• sequencing quality and duplication trends (library complexity)
• mapping rates and read filtering summaries
• counts of valid interaction pairs retained after processing
• capture enrichment behavior (reported descriptively as capture/on-target performance)
• replicate concordance when biological replicates are available

For teams that plan to validate specific contacts by orthogonal assays, targeted 3C derivatives can complement capture-based maps; see the 3C-Seq service overview.

Experimental considerations before starting a Promoter Capture Hi-C project

Promoter capture projects succeed or fail on decisions made before the first library is built. Three pre-start considerations usually determine whether the output will be interpretable.

Sample considerations

• Cell type and state: promoter–enhancer wiring is context-dependent; sampling the wrong cell type can produce a technically clean but biologically irrelevant map.
• Input limitations: low-input samples may be feasible, but feasibility is not the same as interpretability. The success criterion should be the level of promoter contact evidence you need to support your downstream decisions.
• Genome context: repetitive content, CNVs, and complex loci can complicate mapping and interaction calling.

Biological question definition

Be explicit about what you are trying to decide:

• Are you mapping the promoter interactome broadly, or prioritizing targets for a defined set of variants/loci?
• How will you define the promoter set (all annotated promoters vs a subset)?
• What makes an interaction "actionable" in your project: reproducible contacts, contacts overlapping active enhancers, condition-specific changes, or concordance with expression changes?

Controls and replication

• Biological replication strengthens claims about condition- or cell-type-specific wiring.
• Matched handling reduces batch artifacts that can masquerade as interaction differences.
• Design choices affect interpretation: a promoter-centered map can prioritize targets, but conclusions about regulation are stronger when contact evidence is coupled to functional readouts.

A real-world planning vignette (anonymized)

In a typical promoter-focused project, a research team may start with a handful of GWAS loci and a specific cell model (e.g., a primary immune cell subset or a disease-relevant line). During planning, the key decisions are often which promoters to bait (all promoters vs a curated set near loci of interest), how to interpret contacts (prioritizing PIRs that overlap ATAC-seq/H3K27ac peaks in the same cell state), and what constitutes "actionable" evidence (replicate-supported contacts and consistent annotation support).

This kind of upfront definition usually determines whether the final output is a short list of testable promoter–enhancer hypotheses—or an interaction list that's hard to triage.

Frequently asked questions

What is Promoter Capture Hi-C used for?

Promoter Capture Hi-C is used for promoter-centered chromatin interaction mapping, enabling researchers to detect and prioritize distal regions that physically contact gene promoters.

How is Promoter Capture Hi-C different from Hi-C?

Hi-C provides a genome-wide interaction map suited to global architecture features, whereas promoter capture enriches promoter-associated ligation products to increase sensitivity for promoter-centered contacts.

Can Promoter Capture Hi-C identify enhancer target genes?

It can provide evidence of physical promoter–regulatory element interactions that helps prioritize candidate target genes in Research Use Only settings. Functional confirmation typically requires orthogonal evidence (e.g., perturbation and expression changes).

What samples are suitable for Promoter Capture Hi-C?

Suitability depends on the biological objective, the relevance of the chosen cell type/state, and sample quality/quantity constraints. A brief design discussion is often the fastest way to determine whether a promoter capture strategy matches the question.

Note: The list above highlights commonly cited foundational and methods papers; teams may add cell-type-specific or disease-area references relevant to their system.

Next steps

Researchers planning promoter-centered chromatin interaction studies should select methods based on biological questions, target regions, and the level of interaction sensitivity required for defensible interpretation.

If you are designing a Promoter Capture Hi-C study to connect regulatory regions with target genes, discuss your project design with CD Genomics scientists.

---

About the authors

This article was prepared by the CD Genomics Chromatin3D Genomics research team, which supports academic and biotech R&D groups with study design, wet-lab execution, and bioinformatics for 3D genome and chromatin interaction projects.

Review and update process

• Technical review: Content is reviewed internally by scientists experienced in 3C-derived methods (e.g., Hi-C/Capture Hi-C) to ensure terminology, scope, and limitations are presented accurately.
• Scope: Research Use Only. Chromatin interaction evidence supports hypothesis generation and prioritization, but does not by itself establish causal regulation.
• Last updated: 2026-07-22

If you would like help selecting the most appropriate promoter-focused design for your loci and cell system, you can discuss your study objectives with CD Genomics scientists.